A complaint-in-intervention filed in August 2022 alleged that Mr. Shah violated the False Claims Act by causing his labs to bill Medicare for expensive molecular tests that were not ordered by a medical provider. The following companies that Mr. Shah owns were also named in the complaint: United Diagnostics Lab, Tomoka Medical Lab, Tennessee Valley Regional Laboratory, Luminus Diagnostics and Golden Rule Management.
A district court on Sept. 21, 2023, granted the federal government’s motion for default judgment, awarding judgment in favor of the U.S. and against the defendants in the amount of:
– $105.6 million for Mr. Shah
– $6.2 million for Tomoka Medical Lab
– $24 million for Tennessee Valley Regional Laboratories
– $75.5 million for Luminus Diagnostics
– $105.6 million for Golden Rule Management
– $54.6 million for United Diagnostics Lab
Mr. Shah received a prison sentence in 2021 for a criminal contempt charge stemming from his violation of court orders related to the fraud investigation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
